Clinical trials center joins ProSciento’s program for NASH trial recruitment

By Maggie Lynch

- Last updated on GMT

(Image: Getty/Klenger)
(Image: Getty/Klenger)

Related tags Clinical trials trial recruitment Clinical research NASH CRO

High Point Clinical Trials Center is partnering with ProSciento to accelerate clinical trial recruitment of patients with NASH and NAFLD.

High Point Clinical Trials Center enters a three-year collaboration with ProSciento, a contract research organization (CRO) focused on metabolic diseases, as the center becomes a NASH PASS site partner.

The NASH PASS program from ProSciento matches sites with its proprietary methodology to improve enrollment outcomes in clinical trials for non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD).

Lorraine Rusch, president of HPCTC, told us that the center – which focuses on Phase I/II clinical proof of concept and translational medicine studies – was interested in the partnership because of the metrics-driven approach ProSciento uses as a means to drive faster recruitment of ”very valuable” patients in a quantitative manner. 

Through this partnership, HPCTC will use the NASH PASS protocol to identify individuals eligible for enrollment and contribute to the programs database of prospective clinical study participants evaluated for NAFLD and NASH studies. The center will use a combination of transient elastography (fibroscan), proprietary algorithms, and non-invasive biomarker testing, to determine enrollment eligibility.

In a statement, Rusch added: “These much-needed efforts will spur rapid recruitment of patients into clinical trials which directly translates into novel pharmaceutical products and new methodologies for earlier treatment of this emerging metabolic epidemic.”

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers

Follow us

Webinars

Headlines